Navarro, Mavin L.
HRN: 21-46-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
CEFUROXIME 750MG (VIAL)
06/13/2022
06/19/2022
IV
750mg
Q8
T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes